Hematological malignanciesMELLSTEDT, Hakan; BARISTA, Ibrahim; DIMOPOULOS, Meletios et al.Annals of oncology. 2006, Vol 17, issn 0923-7534, x135-x159, SUP10Conference Paper

Antiangiogenic therapy in hematologic malignancies : HaematologyMOEHLER, T. M; HILLENGASS, J; GOLDSCHMIDT, H et al.Current pharmaceutical design. 2004, Vol 10, Num 11, pp 1221-1234, issn 1381-6128, 14 p.Article

The clinical use of antibodies in haematological malignanciesLOPEZ-GUILLERMO, A; MERCADAL, S.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix51-ix57, SUP9Conference Paper

Cytogénétique et hémopathies malignes (à l'exception des lymphomes) = Cytogenetics and malignant hemopathyFENAUX, P; LAI, J. L; KERCKAERT, J. P et al.Lille médical (1987). 1989, Vol 29, Num 1, pp 27-31, 5 p.Article

Les lymphomes malins non hodgkiniens chez le sujet âgé. A propos de 34 observations = Non-Hodgkin lymphomas in elderly patients. A study of 34 casesLEDERLIN, P; BOMAN, F; WITZ, F et al.Annales médicales de Nancy et de l'Est. 1991, Vol 30, Num 2, pp 159-161, issn 0221-3796, 3 p.Article

New sources of drugs for hematologic malignanciesSUKHAI, Mahadeo A; SPAGNUOLO, Paul A; WEIR, Scott et al.Blood. 2011, Vol 117, Num 25, pp 6747-6755, issn 0006-4971, 9 p.Article

SNP array analysis in hematologic malignancies: avoiding false discoveriesHEINRICHS, Stefan; CHENG LI; LOOK, A. Thomas et al.Blood. 2010, Vol 115, Num 21, pp 4157-4161, issn 0006-4971, 5 p.Article

ASH 2002 : nouveautés cliniques et biologiques dans les hémopathies malignesROCHANT, Henri; SIGAUX, François.Hématologie (Montrouge). 2003, Vol 9, Num 2, issn 1264-7527, 39 p., NSSerial Issue

BCR/ABL P190 transgenic mice develop leukemia in the absence of CrklHEMMERYCKX, Bianca; REICHERT, Anja; WATANABE, Meguru et al.Oncogene (Basingstoke). 2002, Vol 21, Num 20, pp 3225-3231, issn 0950-9232Article

CML: Molecular mechanisms & therapeutic strategiesARLINGHAUS, Ralph B.Oncogene (Basingstoke). 2002, Vol 21, Num 56, issn 0950-9232, 141 p.Serial Issue

Meeting of the European Haematology AssociationBritish journal of haematology. Supplement. 1996, Vol 93, Num 2, issn 0963-1860, 397 p.Conference Proceedings

2-chlorodeoxyadenosine treatment of lymphoid malignanciesPIRO, L. D.Blood. 1992, Vol 79, Num 4, pp 843-845, issn 0006-4971Article

Secondary leukaemias after epipodophyllotoxinsCHING-HON PUI; RAIMONDI, S. C; CRIST, W. M et al.Lancet (British edition). 1992, Vol 340, Num 8820, pp 672-673, issn 0140-6736Article

Clinical features and biological implications of acute mixed lineage (hybrid) leukemiasALTMAN, A. J.The American journal of pediatric hematology/oncology. 1990, Vol 12, Num 2, pp 123-133, issn 0192-8562, 11 p.Article

Pattern of infection in hematologic malignancies: an Indian experienceADVANI, S. H; BANAVALI, S. D.Reviews of infectious diseases. 1989, Vol 11, pp S1621-S1628, issn 0162-0886, suppl. 7Conference Paper

Altérations des récepteurs du PDGF dans les hémopathies malignesDEMOULIN, J.-B.Louvain médical. 2012, Vol 131, Num 5, pp 219-222, issn 0024-6956, 4 p.Article

New insights into molecular mechanisms of haematological malignanciesFEY, M. F.Annals of oncology. 2008, Vol 19, issn 0923-7534, v59-v62, SUP5Conference Paper

Recent therapeutic advances in hematological malignancies : dealing with treatment-related complicationsLUDWIG, H; ZOJER, N.Annals of oncology. 2008, Vol 19, issn 0923-7534, v71-v78, SUP5Conference Paper

Ten-year survival in multiple myeloma : report of two cases and review of the literatureROSNER, F; GRÜNWALD, H. W; KALMAN, A. C et al.New York State journal of medicine. 1992, Vol 92, Num 7, pp 316-318, issn 0028-7628Article

Myélome multiple : approches thérapeutiques actuelles = Multiple myeloma: current therapeutic approachesTROUSSARD, X; BAUDUER, F; LEPORRIER, M et al.Bulletin du cancer. 1992, Vol 79, Num 3, pp 231-242, issn 0007-4551Article

The Immunoproteasome as a Target in Hematologic MalignanciesKUHN, Deborah J; ORLOWSKI, Robert Z.Seminars in hematology. 2012, Vol 49, Num 3, pp 258-262, issn 0037-1963, 5 p.Article

Les syndromes myélodysplasiques = Myelodysplastic syndromesBEYNE-RAUZY, O.La Revue de médecine interne (Paris). 2012, Vol 33, issn 0248-8663, A21-A23, HSConference Paper

The fundamental role of epigenetics in hematopoietic malignanciesGALM, Oliver; HERMAN, James G; BAYLIN, Stephen B et al.Blood reviews. 2006, Vol 20, Num 1, pp 1-13, issn 0268-960X, 13 p.Article

Aspects pharmacoéconomiques du traitement des anémies dans les hémopathies malignesZAMBROWSKI, Jean-Jacques.Hématologie (Montrouge). 2006, Vol 12, pp 38-43, issn 1264-7527, 6 p., NS3Article

Les syndromes myélodysplasiquesFENAUX, Pierre.Hématologie (Montrouge). 2006, Vol 12, pp 39-42, issn 1264-7527, 4 p., NS2Conference Paper